CN101242813A - 包含芳基-杂环化合物的毫微粒和控制释放组合物 - Google Patents

包含芳基-杂环化合物的毫微粒和控制释放组合物 Download PDF

Info

Publication number
CN101242813A
CN101242813A CNA2006800302325A CN200680030232A CN101242813A CN 101242813 A CN101242813 A CN 101242813A CN A2006800302325 A CNA2006800302325 A CN A2006800302325A CN 200680030232 A CN200680030232 A CN 200680030232A CN 101242813 A CN101242813 A CN 101242813A
Authority
CN
China
Prior art keywords
composition
less
ziprasidone
dosage form
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2006800302325A
Other languages
English (en)
Chinese (zh)
Inventor
J·德韦恩
P·斯达克
N·范宁
G·瑞凯
S·简金斯
G·里弗斯德格
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Perrigo Pharma International DAC
Original Assignee
Elan Pharma International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Pharma International Ltd filed Critical Elan Pharma International Ltd
Publication of CN101242813A publication Critical patent/CN101242813A/zh
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CNA2006800302325A 2005-06-20 2006-06-19 包含芳基-杂环化合物的毫微粒和控制释放组合物 Pending CN101242813A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69209605P 2005-06-20 2005-06-20
US60/692,096 2005-06-20
US11/372,857 2006-03-10

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN2010102092071A Division CN101879140A (zh) 2005-06-20 2006-06-19 包含芳基-杂环化合物的毫微粒和控制释放组合物

Publications (1)

Publication Number Publication Date
CN101242813A true CN101242813A (zh) 2008-08-13

Family

ID=39933852

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2006800302325A Pending CN101242813A (zh) 2005-06-20 2006-06-19 包含芳基-杂环化合物的毫微粒和控制释放组合物

Country Status (4)

Country Link
JP (1) JP2008546781A (enExample)
CN (1) CN101242813A (enExample)
MX (1) MX2007016151A (enExample)
ZA (1) ZA200710715B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107205964A (zh) * 2014-12-03 2017-09-26 威力塞帕特治疗股份有限公司 使用调节释放索拉贝隆用于下尿路症状的组合物和方法
CN108514545A (zh) * 2011-07-28 2018-09-11 来普卡公司 包含17-羟基孕酮酯的口服组合物和相关方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150366A (en) * 1998-06-15 2000-11-21 Pfizer Inc. Ziprasidone formulations
BRPI0414082A (pt) * 2003-09-02 2006-10-24 Pfizer Prod Inc formas de dosagem de liberação sustentada de ziprasidona
KR20070119678A (ko) * 2005-04-13 2007-12-20 화이자 프로덕츠 인코포레이티드 지속 방출되는 나노입자 조성물을 제공하기 위한주사가능한 저장소 제제 및 방법

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108514545A (zh) * 2011-07-28 2018-09-11 来普卡公司 包含17-羟基孕酮酯的口服组合物和相关方法
US11471470B2 (en) 2011-07-28 2022-10-18 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
CN107205964A (zh) * 2014-12-03 2017-09-26 威力塞帕特治疗股份有限公司 使用调节释放索拉贝隆用于下尿路症状的组合物和方法

Also Published As

Publication number Publication date
ZA200710715B (en) 2009-03-25
JP2008546781A (ja) 2008-12-25
MX2007016151A (es) 2008-03-06

Similar Documents

Publication Publication Date Title
US8119163B2 (en) Nanoparticulate and controlled release compositions comprising cefditoren
AU2007260822B2 (en) Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone
CN101171000A (zh) 包含环孢菌素的毫微粒和控制释放组合物
US20080102121A1 (en) Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone
US20080113025A1 (en) Compositions comprising nanoparticulate naproxen and controlled release hydrocodone
CN101495096A (zh) 纳米微粒泊沙康唑制剂
CN101259106A (zh) 含有头孢菌素的纳米控释组合物
CN101237868A (zh) 纳米粒氯吡格雷和阿司匹林组合制剂
CN101160118A (zh) 多西紫杉醇或其类似物的纳米微粒制剂
CN101484170A (zh) 包含纳米颗粒萘普生和控释氢可酮的组合物
US20080317843A1 (en) Nanoparticulate formulations of modafinil
US20090297596A1 (en) Nanoparticulate and Controlled Release Compositions Comprising a Platelet Aggregation Inhibitor
CN101287453A (zh) 包含头孢菌素的毫微粒和控制释放组合物
CN101879140A (zh) 包含芳基-杂环化合物的毫微粒和控制释放组合物
CN101242813A (zh) 包含芳基-杂环化合物的毫微粒和控制释放组合物
CN101132768A (zh) 纳米颗粒他克莫司制剂
JP2009517485A (ja) セフジトレンを含むナノ粒子状および制御放出組成物
AU2006343445B2 (en) Nanoparticulate and controlled release compositions comprising a platelet aggregation inhibitor
JP2008540550A (ja) ビタミンｋ２を含むナノ粒子および制御放出組成物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20080813